Apart from vascular resistance mechanisms, endothelial EphB4 overexpression induced a reduction of proapoptotic and antiproliferative effects of sunitinib indicating resistance mechanisms in glioma cells. This evidence concerns the gene EPHB4 and central nervous system cancer.